The former heavyweight champion says psychedelics would have helped him with his mental health during his career. Some scientists and companies agree
Psychedelics
Getting People to Help Changes Everything: William Cook, CEO of MindLeap
Mydecine Innovations Group is a psychedelics company that The Dales Report has been watching closely this past year.
Magic Mushrooms Helped Me Cope With Postpartum Depression
In 2014, during my first pregnancy, I felt happy and healthy almost all the time.
MindMed’s New CEO Well-Prepared For Next Stage of Corporate Development
Co-Founder JR Rahn has stepped down as CEO of MindMed. His replacement, Robert Barrow, brings a wealth of clinical trials experience.
Entheon Biomedical's Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit Now Available for Sale in US
HaluGen Life Sciences' test evaluates an individual's overall sensitivity and risk profile associated with psychedelic-assisted therapy
MindMed Announces Chief Executive Officer Transition
JR Rahn is stepping down as MindMed's CEO, to be replaced by Chief Development Officer, Robert Barrow.
Red Light Holland Closes Acquisition of Cutting Edge Silicon Valley Applied Sciences Company Radix Motion, Becoming a Leader in Psychedelic Technology
Red Light Holland's new tech acquisition is intended to help optimize psychedelics dosing.
Field Trip Health Ltd. Applies to List Its Common Shares on the NASDAQ Stock Market
After just uplisting to the TSX in Canada, Field Trip Health has applied to uplist to the NASDAQ in the U.S.
Cybin Launches EMBARK and Co-Sponsors First Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Burnout and Distress with Psychedelic-Assisted Psychotherapy
Cybin is launching a new clinical trial to address "COVID-related burnout and distress", supported by its new EMBARK psychotherapy model.
Seattle City Council Promotes Psychedelics As Potential Tool Against Opioid Epidemic
Seattle lawmakers on Monday sent a letter to members of a local task force focused on the opioid overdose epidemic, imploring the group to investigate the therapeutic potential of psychedelics like ayahuasca and ibogaine in curbing addiction.
Optimi Health Announces Product Distribution Agreement with Vitasave
Optimi Health's new distribution agreement with Vitasave provides retail access to two of Canada's largest urban markets.
Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms
Mydecine announces identifying 40 previously unknown "novel compounds" among dozens of mushroom species it has screened.
Are Psychedelics The Ultimate Brain-Repair Drugs?
Psychedelic drugs increasingly appear to be powerful medicinal tools to rebuild broken brains.
Field Trip Virtually Opens The Market
Field Trip Health has uplisted to the TSX in Canada.
Psilocybin therapy appears to be at least as effective as a leading conventional antidepressant
Psilocybin, the active compound in magic mushrooms, may be at least as effective as selective serotonin reuptake inhibitors, the leading type of antidepressant medication, according to research published in the New England Journal of Medicine.